These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 989015)

  • 21. [Clinical experimental studies with the heart glycoside, proscillaridin, with special reference to its enteral resorption rate].
    Belz GG
    Med Klin; 1968 Jan; 63(3):96-102. PubMed ID: 5691836
    [No Abstract]   [Full Text] [Related]  

  • 22. [Trial of a combination of proscillaridin A, thioridazine and Cori ester in the ambulatory treatment of some cardiopathies, especially senile types].
    Bellardo G; Pichierri U
    Minerva Med; 1976 Sep; 67(46):2985-90. PubMed ID: 967364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man.
    Andersson KE; Bergdahl B; Wettrell G
    Eur J Clin Pharmacol; 1977 Apr; 11(4):273-6. PubMed ID: 862647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.
    Belz GG; Schreiter H; Wolf GK
    Eur J Clin Pharmacol; 1976 Jun; 10(2):101-8. PubMed ID: 786669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of cardiac glycosides on the duration of systole. A comparison between proscillaridin and strophanthin].
    Heierli C; Schweizer W; Burkart F
    Schweiz Med Wochenschr; 1971 May; 101(18):638-42. PubMed ID: 5103642
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
    Burkert K; Beckmann H
    Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical experience in the use of proscillaridin A in cardiac patients with tubercular bronchopneumopathy].
    Concina E; Spataro C; Migliaccio A; Piacenza G
    Minerva Med; 1971 Apr; 62(34):1769-82. PubMed ID: 5103638
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
    Benda L; Zenz W
    Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proscillaridin activity in portal and peripheral venous blood after oral administration to man.
    Andersson KE; Bergdahl B; Dencker H; Wettrell G
    Eur J Clin Pharmacol; 1977 Apr; 11(4):277-81. PubMed ID: 862648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic trial of an association of theophylline and proscillaridin A in the treatment of cor pulmonale and of some decompensated heart diseases].
    Ballerini C; Fontana A
    Minerva Med; 1971 Mar; 62(23):1225-37. PubMed ID: 5103269
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: Studies on pharmacokinetics of proscillaridin-4'-methyl ether in man.
    Belz GG
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R7. PubMed ID: 4276519
    [No Abstract]   [Full Text] [Related]  

  • 32. [Plasma levels and electrocardiogram after intravenous administration of proscillaridin and digoxin].
    Belz GG; Rudofsky G; Lossnitzer K; Wolf G; Sauch M
    Z Kardiol; 1974 Mar; 63(3):201-11. PubMed ID: 4471866
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of high intravenous doses of D-penicillamine on toxic actions of cardiac glycosides in the guinea pig. Short communication (author's transl)].
    Neugebauer G
    Arzneimittelforschung; 1977; 27(11):2073-4. PubMed ID: 580003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
    Kubinyi H
    Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect and plasma level of methylproscillaridin and beta-acetyldigitoxin following long term administration in man].
    Belz GG; Nübling H; Strauch M
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():315-9. PubMed ID: 821263
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism and excretion of methylproscillaridin by man.
    Rietbrock N; Staud R
    Eur J Clin Pharmacol; 1975 Aug; 8(6):427-32. PubMed ID: 1233244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects.
    Kovarik JM; Hartmann S; Bartlett M; Riviere GJ; Neddermann D; Wang Y; Port A; Schmouder RL
    Biopharm Drug Dispos; 2007 Mar; 28(2):97-104. PubMed ID: 17230596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 39. Stability in vitro of methylproscillaridin.
    Bergdahl B; Andersson KE
    Eur J Clin Pharmacol; 1977 Apr; 11(4):267-71. PubMed ID: 16755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)].
    Stauch M; Grewe N; Belz GG
    Klin Wochenschr; 1977 Jul; 55(14):705-6. PubMed ID: 330937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.